These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 12123401)

  • 1. The new definition of myocardial infarction: diagnostic and prognostic implications in patients with acute coronary syndromes.
    Meier MA; Al-Badr WH; Cooper JV; Kline-Rogers EM; Smith DE; Eagle KA; Mehta RH
    Arch Intern Med; 2002 Jul; 162(14):1585-9. PubMed ID: 12123401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of outcome after percutaneous coronary intervention for the acute coronary syndrome.
    Kini AS; Lee PC; Mitre CA; Kim MC; Kamran M; Duffy ME; Marmur JD; Sharma SK
    Am J Med; 2003 Dec; 115(9):708-14. PubMed ID: 14693323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of high-risk acute coronary syndromes and eligibility for glycoprotein IIb/IIIa inhibitors among patients admitted for possible myocardial ischemia.
    Kontos MC; Ornato JP; Schmidt KL; Tatum JL; Jesse RL
    Am Heart J; 2002 Jan; 143(1):70-5. PubMed ID: 11773914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Erlanger chest pain evaluation protocol: a one-year experience with serial 12-lead ECG monitoring, two-hour delta serum marker measurements, and selective nuclear stress testing to identify and exclude acute coronary syndromes.
    Fesmire FM; Hughes AD; Fody EP; Jackson AP; Fesmire CE; Gilbert MA; Stout PK; Wojcik JF; Wharton DR; Creel JH
    Ann Emerg Med; 2002 Dec; 40(6):584-94. PubMed ID: 12447334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of cardiac troponin I re-elevation following percutaneous coronary intervention in high-risk patients with acute coronary syndromes.
    Fuchs S; Gruberg L; Singh S; Stabile E; Duncan C; Wu H; Waksman R; Satler LF; Pichard AD; Kent KM; Kornowski R
    Am J Cardiol; 2001 Jul; 88(2):129-33. PubMed ID: 11448408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-reactive protein in patients with acute coronary syndrome: correlation with diagnosis, myocardial damage, ejection fraction and angiographic findings.
    Brunetti ND; Troccoli R; Correale M; Pellegrino PL; Di Biase M
    Int J Cardiol; 2006 May; 109(2):248-56. PubMed ID: 16055214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of redefining acute myocardial infarction on incidence, management and reimbursement rate of acute coronary syndromes.
    Polanczyk CA; Schneid S; Imhof BV; Furtado M; Pithan C; Rohde LE; Ribeiro JP
    Int J Cardiol; 2006 Feb; 107(2):180-7. PubMed ID: 16412794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment modalities of non-ST-elevation acute coronary syndromes in the real world. Results of the prospective R.OS.A.I.-2 registry.
    Registro Osservazionale Angina Instabile Investigators
    Ital Heart J; 2003 Nov; 4(11):782-90. PubMed ID: 14699708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An integrated clinical approach to predicting the benefit of tirofiban in non-ST elevation acute coronary syndromes. Application of the TIMI Risk Score for UA/NSTEMI in PRISM-PLUS.
    Morrow DA; Antman EM; Snapinn SM; McCabe CH; Theroux P; Braunwald E
    Eur Heart J; 2002 Feb; 23(3):223-9. PubMed ID: 11792137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiological consequences of introducing new biochemical markers for detection of acute myocardial infarction.
    Graven T; Krüger O; Brønstad G
    Scand Cardiovasc J; 2001 Sep; 35(4):233-7. PubMed ID: 11759116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of the revised criteria for acute myocardial infarction using cardiac troponins in a Japanese population with acute coronary syndromes.
    Yamamoto T; Yasutake M; Takagi H; Akutsu K; Fujita N; Kasagami Y; Sato N; Nakagomi A; Kusama Y; Takayama M; Tanaka K; Takano T
    Circ J; 2005 Jul; 69(7):774-9. PubMed ID: 15988101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delta creatine kinase-MB outperforms myoglobin at two hours during the emergency department identification and exclusion of troponin positive non-ST-segment elevation acute coronary syndromes.
    Fesmire FM; Christenson RH; Fody EP; Feintuch TA
    Ann Emerg Med; 2004 Jul; 44(1):12-9. PubMed ID: 15226704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of patients with acute coronary syndrome with and without systemic hypertension.
    Majahalme SK; Smith DE; Cooper JV; Kline-Rogers E; Mehta RH; Eagle KA; Bisognano JD
    Am J Cardiol; 2003 Aug; 92(3):258-63. PubMed ID: 12888127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of myocardial infarction as an end point in two large trials of acute coronary syndromes.
    Mahaffey KW; Roe MT; Kilaru R; French JK; Alexander JH; Berdan LG; Van De Werf F; Simoons ML; Weaver WD; White HD; Lincoff AM; Kleiman NS; Topol EJ; Harrington RA
    Am J Cardiol; 2005 Jun; 95(12):1404-8. PubMed ID: 15950560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between minor elevations of creatine kinase-MB level and mortality in patients with acute coronary syndromes without ST-segment elevation. PURSUIT Steering Committee. Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy.
    Alexander JH; Sparapani RA; Mahaffey KW; Deckers JW; Newby LK; Ohman EM; Corbalán R; Chierchia SL; Boland JB; Simoons ML; Califf RM; Topol EJ; Harrington RA
    JAMA; 2000 Jan; 283(3):347-53. PubMed ID: 10647797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term prognostic value of serial troponin T bedside tests in patients with acute coronary syndromes.
    van Domburg RT; Cobbaert C; Kimman GJ; Zerback R; Simoons ML
    Am J Cardiol; 2000 Sep; 86(6):623-7. PubMed ID: 10980212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular outcome in hospitalized patients with minimal troponin I elevation and normal creatine phosphokinase.
    Srivathsan K; Showalter J; Wilkens J; Hurley B; Abbas A; Loutfi H
    Int J Cardiol; 2004 Nov; 97(2):221-4. PubMed ID: 15458687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of thrombolysis with alteplase (50 mg) plus tirofiban versus alteplase (100 mg) alone in acute myocardial infarction: preliminary findings.
    Sarullo FM; Pasquale PD; D'Alfonso G; Amerigo L; Cannizzaro S; Castello A
    Ital Heart J; 2001 Aug; 2(8):605-11. PubMed ID: 11577835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Creatine kinase-MB fraction elevation after percutaneous coronary intervention in patients with chronic renal failure.
    Gruberg L; Mehran R; Waksman R; Dangas G; Fuchs S; Wu H; Kent KM; Pichard AD; Satler LF; Stone GW; Leon MB
    Am J Cardiol; 2001 Jun; 87(12):1356-60. PubMed ID: 11397353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of creatine kinase-MB elevation after percutaneous coronary intervention in patients with chronic renal dysfunction.
    Jeremias A; Albirini A; Ziada KM; Chew DP; Brener SJ; Topol EJ; Ellis SG
    Am Heart J; 2002 Jun; 143(6):1040-5. PubMed ID: 12075261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.